Want to see IN:SUVEN full AI Analyst Report?
Suven Life Sciences Limited (SUVEN) Financial Statements
Suven Life Sciences Limited Financial Overview
Suven Life Sciences Limited's market cap is currently $72.93B. The company's EPS TTM is $-12.41; its P/E ratio is -17.77; and it has a dividend yield of 11.14%. Suven Life Sciences Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 71.15M | $ 66.56M | $ 116.93M | $ 135.39M | $ 118.44M |
| Gross Profit | $ -419.28M | $ -276.33M | $ 108.69M | $ 129.74M | $ -137.31M |
| Operating Income | $ -2.90B | $ -1.72B | $ -1.23B | $ -1.32B | $ -1.26B |
| EBITDA | $ -2.71B | $ -1.55B | $ -994.18M | $ -1.11B | $ -1.17B |
| Net Income | $ -2.76B | $ -1.61B | $ -1.05B | $ -1.18B | $ -1.22B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.18B | $ 600.05M | $ 2.40B | $ 2.31B | $ 504.36M |
| Total Assets | $ 6.24B | $ 1.35B | $ 2.85B | $ 3.89B | $ 1.08B |
| Total Debt | $ 166.94M | $ 0.00 | $ 7.10M | $ 16.05M | $ 32.09M |
| Net Debt | $ -3.21B | $ -377.26M | $ -142.23M | $ -354.14M | $ -20.65M |
| Total Liabilities | $ 328.14M | $ 251.97M | $ 148.62M | $ 135.91M | $ 118.89M |
| Stockholders' Equity | $ 5.91B | $ 1.10B | $ 2.70B | $ 3.75B | $ 961.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.03B | $ -1.86B | $ -1.15B | $ -1.06B | $ -1.47B |
| Operating Cash Flow | $ -2.98B | $ -1.48B | $ -1.15B | $ -1.03B | $ -1.28B |
| Investing Cash Flow | $ -4.66B | $ 1.49B | $ 944.36M | $ -2.61B | $ -222.29M |
| Financing Cash Flow | $ 7.57B | $ -7.10M | $ -10.54M | $ 3.96B | $ 1.46B |
Currency in INR